# Acclinate

> Digital health equity platform using NOWINCLUDED community engagement and AI to improve clinical trial diversity.

## Why it is interesting

FDA and pharma pressure on trial diversity created a commercial market Acclinate attacks with a community product (NOWINCLUDED) plus AI recruitment tech — not another patient-finder agency. Birmingham HQ; Series A led by a drug-distribution giant’s venture arm.

## Profile

- **Stage:** series-a
- **Status:** private
- **Industries:** healthtech
- **Coverage:** full
- **Last updated:** 2026-07-26

## Key facts

- Series A (May 2024): $7M led by Cencora Ventures; Labcorp and Latimer Ventures participated
- NOWINCLUDED community platform plus e-DICT AI for clinical trial diversity
- HQ Birmingham, AL; founded 2020 by Del Smith and Tiffany Whitlow
- Seed backing includes Birmingham corporate VC 450 Ventures

## Investors in our directory

- https://venturecapitaltracker.com/fund/450-ventures

## Related articles

- https://venturecapitaltracker.com/birmingham-al-startups-and-vc-firms-2026

---
Source: https://venturecapitaltracker.com/startup/acclinate